1. 1132PDClinical efficacy of T-cell therapy after short-term BRAF-inhibitor induction in checkpoint inhibitor resistant metastatic melanoma patients. (23rd October 2018) Authors: Borch, T H; Andersen, R; Rana, M A H; Kongsted, P; Pedersen, M; Nielsen, M; Kjeldsen, J W; Kverneland, A; Lorentzen, C L; Met, Ö; Donia, M; Svane, I M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 52PDifferential effects of corticosteroids and anti-TNF on tumor-specific immune responses: Implications for the management of irAEs. (17th December 2018) Authors: Draghi, A; Borch, T H; Radic, H D; Chamberlain, C; Gokuldass, A; Svane, I-M; Donia, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression. (24th April 2018) Authors: Andersen, R; Borch, T H; Draghi, A; Gokuldass, A; Rana, M A H; Pedersen, M; Nielsen, M; Kongsted, P; Kjeldsen, J W; Westergaard, M C W; Radic, H D; Chamberlain, C A; Hölmich, L R; Hendel, H W; Larsen, M S; Met, Ö; Svane, I M; Donia, M Journal: Annals of oncology Issue: Volume 29:Number 7(2018) Page Start: 1575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗